3 Biotech Stocks to Avoid: Amarin, Dendreon, and Prosensa
Amarin, Dendreon, and Prosensa are three biotech stocks which should be avoided at all costs. Here’s why.
America's Top 5 Health Threats in 2014
There are 12,420 diseases, disorders, and ailments according to W.H.O., but these are the five health risks most concerning to the CDC in 2014.
2 Health Care Partnerships Go Head-To-Head
While the partnership between GlaxoSmithKline (NYSE: GSK) and Ligand (NASDAQ: LGND) seems to be moving forward, the partnership between Roche (OTCMKTS: RHHBY) and PDL (NASDAQ: PDLI) has seemingly reached its end
Stocks: In Insider Trading, GlaxoSmithKline Buys Shares of Theravance
Plus, Marubeni buys shares of Aircastle; Shutterfly and Jacob's Engineering Group see purchases.